LOCAL RECURRENCE AND
SURVIVAL IN PROSPECTIVE RANDOMIZED TRIALS COMPARING CS WITH AND WITHOUT RT
(CS = conservative surgery, i.e. lumpectomy and RT = radiation therapy)
|
Breast Recurrence % |
Overall Survival % |
Interval Results |
|||
| Trial | CS | CS+RT | CS | CS+RT | Reported |
| NSABP B-06 18, 65 | 35 | 10 | 58 | 62 | 12-year actuarial |
| Milan III 64, 109 | 18 | 2 | 92 | 92 | 5-year actuarial |
| Uppsala-Orebro 110 | 24 | 9 | 78 | 78 | 10-year actuarial |
| Ontario 111 | 40 | 18 | 72 | 74 | 10-year actuarial |
| NSABP B-2 184 | 17 | 3 | 8-year actuarial | ||
| Scottish 112 | 28 | 6 | 93 | 93 | 5-year actuarial |
| ER-positive | 25 | 3 | |||
| ER-negative | 44 | 14 | |||
| St. George's, UK 113 | 35 | 13 | 5-year actuarial | ||
| BASO II, UK 114 | 5 | <2 | 98 | 98 | Crude 4-year median |
| West Midlands 115 | 13 | 4 | Crude 2-year mean | ||
| Swedish 116 | 14 | 4 | 93 | 94 | 5-year actuarial |
| CALGB 117 | 1.3 | 0 | 28-month crude | ||
| British Columbia 118 | 5.7 | 0.5 | 3.4-year crude | ||
| CRC, UK 119 | 69% reduction | No difference | Crude 9.7-median | ||